Comment on: Emergence of severe spondyloar-thropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease

Alivernini Stefano; Pugliese Daniela; Tolusso Barbara; Felice Carla; Gremese Elisa; Armuzzi Alessandro

首页> 外文期刊>Rheumatology >Comment on: Emergence of severe spondyloar-thropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease

【24h】

Comment on: Emergence of severe spondyloar-thropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease

机译：评论：在炎症性肠病成功vedolizumab治疗后，患有严重脊椎病相关患者病理的出现

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Rheumatology》 |2019年第6期|共4页
作者
Alivernini Stefano; Pugliese Daniela; Tolusso Barbara; Felice Carla; Gremese Elisa; Armuzzi Alessandro;
展开▼
作者单位

Fdn Policlin Univ A Gemelli IRCCS Div Rheumatol Rome Italy;

Fdn Policlin Univ A Gemelli IRCCS Div Gastroenterol Presidio Columbus IBD Unit Rome Italy;

Fdn Policlin Univ A Gemelli IRCCS Div Rheumatol Rome Italy;

Fdn Policlin Univ A Gemelli IRCCS Div Gastroenterol Presidio Columbus IBD Unit Rome Italy;

Fdn Policlin Univ A Gemelli IRCCS Div Rheumatol Rome Italy;

Fdn Policlin Univ A Gemelli IRCCS Div Gastroenterol Presidio Columbus IBD Unit Rome Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Comment on: Emergence of severe spondyloar-thropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease [J] . Alivernini Stefano, Pugliese Daniela, Tolusso Barbara, Rheumatology . 2019,第6期

机译：评论：在炎症性肠病成功vedolizumab治疗后，患有严重脊椎病相关患者病理的出现
2. Comment on: Emergence of severe spondyloar-thropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease: reply [J] . Dubash S., Marzo-Ortega H., McGonagle D. Rheumatology . 2019,第6期

机译：评论：在成功的Vedolizumab治疗炎症肠道疾病后，严重乳突性相关患有病理学的出现：答复：答复
3. Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease [J] . Dubash Sayam, Marianayagam Thiraupathy, Tinazzi Ilaria, Rheumatology . 2019,第6期

机译：成功伏沙尔替之疗法治疗炎症性肠病后，严重脊椎病相关患有患有的出现
4. Natural anti-Inflammatory Compounds for the Management and Adjuvant Therapy of Inflammatory Bowel Disease (IBD) and its Drug Delivery System(DDS) for Targeted to Colon. [C] . Annual meeting exposition of the Controlled Release Society . 2009

机译：用于炎症性肠病（IBD）的管理和佐剂治疗的天然抗炎化合物及其药物递送系统（DDS）用于靶向结肠。
5. Efficacy of the Specific Carbohydrate Diet for the Treatment of Patients with Active, Severe, Biologic-Refractory Inflammatory Bowel Disease [D] . Dabbah, Eliane. 2020

机译：特定碳水化合物饮食治疗活性，严重，生物难治性炎症肠病患者的疗效
6. Efficacy of vedolizumab for induction of clinical response andremission in patients with moderate to severe inflammatory bowel disease whofailed at least two TNF antagonists [O] . Martine De Vos, Barbara Dhooghe, Severine Vermeire, 2000

机译：vedolizumab诱导临床反应和疗效的功效中度至重度炎症性肠病患者缓解至少两种TNF拮抗剂治疗失败
7. Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease [O] . Sayam Dubash, Thiraupathy Marianayagam, Ilaria Tinazzi, 2018

机译：炎症性肠道病成功vedolizumab治疗后，严重脊椎病有关的肌腱病理的出现

Comment on: Emergence of severe spondyloar-thropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease

著录项

相似文献

相关主题

期刊订阅